An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors Journal Article


Authors: Eaby, B.; Culkin, A.; Lacouture, M. E.
Article Title: An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors
Abstract: The use of human epidermal growth factor receptor (HER1/EGFR) inhibitors, such as erlotinib, cetuximab, and panitumumab, often is accompanied by the development of a characteristic spectrum of skin toxicities. Although these toxicities rarely are life threatening, they can cause physical and emotional distress for patients and caregivers. As a result, practitioners often withdraw the drug, potentially depriving patients of a benefcial clinical outcome. These reactions do not necessarily require any alteration in HER1/EGFR-inhibitor treatment and often are best addressed through symptomatic treatment. Although the evidence for using such therapies is limited, an interdisciplinary HER1/EGFR-inhibitor dermatologic toxicity forum was held in October 2006 to discuss the underlying mechanisms of these toxicities and evaluate commonly used therapeutic interventions. The result was a proposal for a simple, three-tiered grading system for skin toxicities related to HER1/EGFR inhibitors to be used in therapeutic decision making and as a framework for building a stepwise approach to intervention.
Keywords: erlotinib; patient selection; antineoplastic agents; conference paper; antineoplastic agent; evidence based medicine; evidence-based medicine; quality control; drug eruption; protein kinase inhibitor; incidence; epidermal growth factor receptor; practice guideline; receptor, epidermal growth factor; algorithms; cetuximab; monoclonal antibody; panitumumab; protein kinase inhibitors; hospitalization; antibodies, monoclonal; drug antagonism; severity of illness index; algorithm; practice guidelines as topic; benchmarking; consensus development; quinazolines; decision trees; quinazoline derivative; drug eruptions; decision tree
Journal Title: Clinical Journal of Oncology Nursing
Volume: 12
Issue: 2
ISSN: 1092-1095
Publisher: Oncology Nursing Society (ONS)  
Date Published: 2008-01-01
Start Page: 283
End Page: 290
Language: English
DOI: 10.1188/08.cjon.283-290
PUBMED: 18390464
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 23" - "Export Date: 17 November 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ann E Culkin
    15 Culkin